1ERA | A:1-62 | TERTIARY STRUCTURE OF ERABUTOXIN B IN AQUEOUS SOLUTION ELUCIDATED BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE |
1FRA | A:1-62 | TERTIARY STRUCTURE OF ERABUTOXIN B IN AQUEOUS SOLUTION ELUCIDATED BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE |
1LSI | A:1-66 | LSIII (NMR, 23 STRUCTURES) |
1NXB | A:1-62 | STRUCTURE AND FUNCTION OF SNAKE VENOM CURARIMIMETIC NEUROTOXINS |
1QKD | A:1-62; B:1-62 | ERABUTOXIN |
1QKE | A:1-62 | ERABUTOXIN |
2ERA | A:1-62 | RECOMBINANT ERABUTOXIN A, S8G MUTANT |
3EBX | A:1-62 | REFINEMENT AT 1.4 ANGSTROMS RESOLUTION OF A MODEL OF ERABUTOXIN B. TREATMENT OF ORDERED SOLVENT AND DISCRETE DISORDER |
3ERA | A:1-62; B:1-62 | RECOMBINANT ERABUTOXIN A (S8T MUTANT) |
5EBX | A:1-62 | THE CRYSTAL STRUCTURE OF ERABUTOXIN A AT 2.0 ANGSTROMS RESOLUTION |
6EBX | A:1-62; B:1-62 | STRUCTURE DETERMINATION OF A DIMERIC FORM OF ERABUTOXIN B, CRYSTALLIZED FROM THIOCYANATE SOLUTION |